Hubei Honch Pharmaceutical Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Hubei Honch Pharmaceutical CO.,Ltd.

17 YRS

Hubei, China

CNY 34.7 Million

19980 m²

100-500 people

Main Products: Vinorelbine L-Tartrate / Vincristine Sulfate / Vincaleukoblastine Sulfate / Mitomycin C / Bortezomib / Epothilone B / Ixabepilone / Staurosporine / Midostaurin / Melphalan Hydrochloride / Lufenuron / Nitenpyram / Doramectin / Milbemite

Hubei, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Hongzhong pharmaceutical was established in 2007, located in lishizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province, covering an area of about 20000 square meters. The company focuses on the R & D and production of innovative antitumor and high-end veterinary drug APIs, and the products are mainly biological fermentation. As a high-tech enterprise, Hongzhong has won a number of domestic and American invention patents and won scientific and technological innovation awards issued by Hubei provincial government for many times. Hongzhong's annual R & D investment accounts for 6 ~ 10% of the sales revenue, and the R & D and quality team accounts for nearly 50% of the company's personnel. Every product of the company put on the market is to analyze competitors on a global scale. After more than ten years of investment and focus, Hongzhong is the exclusive global manufacturer of isapirone API. Vinorelbine tartrate API accounts for more than 30% of the global market share. Licuron API is the first and second manufacturer in the world in China, and many products cooperate with the original researchers.

Basic Information